{"ticker": {"uuid": "c551692f-f2a2-4812-8b1d-cf78a7c43dfc", "symbol": "SOPH", "name": "Sophia Genetics SA", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOb1V3RUpSelQyV1M4TUpvN0h5TTZ6R1d1R3Z2ZkVBUWFtSGMxWFhFWkpobHpQYWJtTFR0eFlpU0l5UGVMRlRaWTUwM2ppWDlBdEVSM1hQbmd6LWhhclVFaFlQb0RUM2FrZTJScHlqRlFJMF9Bay1YakhqSjV2N3hYRS1ZbXFNb1F2cFFWSGlWT2dpcm9yYmtVdmJJQ1RTeTFpcllFcThmVXN5Nl9WZVZKT3Z1RXI4NXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T13:28:55+00:00", "published_display": "22 Jun 2026 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K", "summary": "SOPHiA GENETICS SA (SOPH) has filed a Form 6-K reporting the completion of an underwritten public offering of 12,104,900 ordinary shares at $4.75 per share, generating gross proceeds of approximately $57.5 million. The offering, which closed on June 18, 2026, included the full ex", "url": "https://www.stocktitan.net/sec-filings/SOPH/6-k-sop-hi-a-genetics-sa-current-report-foreign-issuer-c59327d1ba27.html", "source_name": "Stock Titan", "published_at": "2026-06-22T13:28:27", "published_display": "22 Jun 2026 13:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS raises USD 57.5 million through a public offering", "summary": "SOPHiA GENETICS, a leader in AI-driven precision medicine, successfully closed an oversubscribed public offering, raising $57.5 million. The company sold 12,104,900 ordinary shares at $4.75 each, with underwriters fully exercising their option for additional shares, signaling str", "url": "https://www.startupticker.ch/en/news/sophia-genetics-raises-usd-57-5-million-through-a-public-offering", "source_name": "Startupticker.ch", "published_at": "2026-06-22T07:11:27", "published_display": "22 Jun 2026 07:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares", "summary": "SOPHiA GENETICS has successfully closed a public offering of ordinary shares, raising $57.5 million. The offering included the full exercise of the underwriters' option to purchase additional shares, indicating strong market interest and investor confidence in the company. This c", "url": "https://www.fidelity.com/news/article/default/202606190800PR_NEWS_USPR_____NE87865", "source_name": "Fidelity", "published_at": "2026-06-20T01:39:03", "published_display": "20 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS closes $57.5M public offering By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPS19zMVg1VWk1ejVBeGRCOFF6VWUxaS1ndm4xWkJVSHVUSkotY1RSTExCUGJUZ2dJaXRTcFNOcDlUVkplVTNiOFN0Ny1rbDVNNVN1Y1QyMmJLbGQ0QjJTbmZHb1Q0YjlNWTgwZEE3blRhNWotamhDNlExNURueHcwZ2puOHQ2VGRPWE14NEJ2MnFzUGN6a09XQVFvdllmT05uaXFFTWNhOA?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-19T12:13:18+00:00", "published_display": "19 Jun 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS prices $50M public offering at $4.75 per share", "summary": "SOPHiA GENETICS has announced the pricing of a public offering of 10,526,316 ordinary shares at $4.75 per share, aiming to raise approximately $50 million before deductions. The offering is expected to close around June 21, 2024, and includes an option for underwriters to purchas", "url": "https://www.msn.com/en-us/money/topstocks/sophia-genetics-prices-50m-public-offering-at-475-per-share/ar-AA25PRq3", "source_name": "MSN", "published_at": "2026-06-19T00:40:21", "published_display": "19 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS: Strong Growth Meets A Critical Execution Phase (NASDAQ:SOPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQd3V1dzdUbTJWeVFWQmRIZzlSaXdGMFI0Z1FiQXpTTDVFRHpsbEFZR1JGZDlMZjBscTNiUkFSVGhvMHEyNkNsamFvdGZ6REV0MW83b0dDUHVJakhvejdmWGx2YmpIUjlHaXVlcGMyNzZDZlJWZjYtc1R2amVwM0JkMDBVbzdvQ0V6QVBQekxzbU5lQXRVWjZ6R2R6XzgyQ2wwQUNnekN3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T12:22:59+00:00", "published_display": "18 Jun 2026 12:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics SA (SOPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZNGlrNlgzVWo0aDdEZjNkWG5Gd2lLUk04TzNLUWdZOXk2ZjJKdHJkYm5KMU9vaC0tTzVvUWJtRUI1N09feXpOYmRYc054eXd4ajlSTXZ0VWZTTHQ0WU5UdjVxWXRMVXhWR0N1UEpn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T08:30:21+00:00", "published_display": "18 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Zhenyu Xu Sells 4,000 Shares of Sophia Genetics SA", "summary": "Zhenyu Xu, the Chief Scientific Officer of Sophia Genetics SA, sold 4,000 shares of the company on June 15, 2026, reducing his total holdings to 622,280 shares. This transaction is part of a larger trend of insider selling at Sophia Genetics SA, with 57 insider sells against only", "url": "https://www.gurufocus.com/news/8921540/insider-sell-zhenyu-xu-sells-4000-shares-of-sophia-genetics-sa?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-18T01:09:16", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics SA (SOPH) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFB1UUR1VzhqaUx2anRxNDF1a0dvUGlUQ01oMHI2SlFEQWpVb2xtLUd1LWR1VUdPT1BiMDMtSUVnd0xpYkZNWjg5RUtYT1lCNkxfVVdkMUlGNU0wTVFPTnlObW1XUEFIbXRlNWhQVGl3U09FemhnZzVR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:07:49+00:00", "published_display": "17 Jun 2026 21:07", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) offers 10.53M shares; underwriters may add 1.58M", "summary": "SOPHiA GENETICS has announced an offering of 10.526 million ordinary shares at $4.75 per share, aiming to raise gross proceeds of approximately $49.998 million. Underwriters have an option to purchase an additional 1.578 million shares. The net proceeds, estimated at $45.9 millio", "url": "https://www.stocktitan.net/sec-filings/SOPH/424b5-sop-hi-a-genetics-sa-prospectus-supplement-debt-securities-e2a0f6414a7f.html", "source_name": "Stock Titan", "published_at": "2026-06-17T21:09:58", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CSO sells 4,000 shares under 10b5-1 plan", "summary": "SOPHiA GENETICS (SOPH) Chief Scientific Officer Xu Zhenyu sold 4,000 Ordinary Shares in an open-market transaction under a pre-arranged 10b5-1 trading plan. The shares were sold at a weighted average price of $5.0141, ranging from $4.90 to $5.13 per share. Following this transact", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-162eec7c9c8a.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:09:58", "published_display": "17 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPa2xWVnRvWUVZd0llN1dnWHlDc010cThiREItc05qOVpVNHRzZGNHTUJXdjJhRG8waExrbmdGSHZMdm9hVEI5U01UNUIxRjNKWWlCMDJGYUpkZ05LOVFXS0gyZHd2MElLRHBPalNlc2ZxbnRDaDkxMURid0VMVHlzZ0ZQMlZ0QTJaQWVpVHVnQlJMdDJHSG1aRVVIVUxhdC1ScWNvcmtnZjNkQVk0MkxLLWRJSG05cElzYm42enpqR25STWVyQ3JaZUw1U2RaODNFeUNwag?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-17T01:21:00+00:00", "published_display": "17 Jun 2026 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares", "summary": "SOPHiA GENETICS has announced a proposed public offering of its ordinary shares. This news was alerted to Quantisnow Plus members shortly after publication. Quantisnow, a market data and news platform, provides real-time alerts on various financial events including press releases", "url": "https://quantisnow.com/insight/sophia-genetics-announces-proposed-public-offering-of-ordinary-shares-6604860", "source_name": "Quantisnow", "published_at": "2026-06-17T00:09:58", "published_display": "17 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics (SOPH) Launches Public Offering of Ordinary Shar", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZC1FTHMtMlBwRHk3Sk5hZ2NxZmkxSFNXRUpDMW8tQ0JrcjFWZndyd0lWMVNZcmh4U2hTZVF5ZjM2Q0xBN2xZakw4SDZPY3gtRDdaaVBaY2RGc3B0Zk1XT3RUSXRhajFrLTlDZUcxcGhnUnRmSVJzV1djSWk3TDl4bWFwaVlmeHpSM2VsNDFCV0ZkTkZQRUV5MHBUZnZvenlFN2hTWW03bXJBUGRaZloxaGE5THYwUQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-16T21:55:21+00:00", "published_display": "16 Jun 2026 21:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ: SOPH) files supplement for share offering; $5.01 last trade", "summary": "SOPHiA GENETICS has filed a preliminary prospectus supplement for an ordinary share offering, which includes a 30-day option for underwriters to purchase additional shares. The company reported 71,790,366 ordinary shares outstanding as of March 31, 2026, with a last reported Nasd", "url": "https://www.stocktitan.net/sec-filings/SOPH/424b5-sop-hi-a-genetics-sa-prospectus-supplement-debt-securities-9462fbc95acb.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:39:46", "published_display": "16 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS plans new stock sale with option for 15% more shares", "summary": "SOPHiA GENETICS (Nasdaq: SOPH) announced a proposed underwritten public offering of its ordinary shares, with an option for underwriters to purchase an additional 15% of shares. All shares will be newly issued by the company, and the offering's size, price, and timing are subject", "url": "https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-proposed-public-offering-of-ordinary-q4oghzd1l1ic.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:39:46", "published_display": "16 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS stock falls on share offering announcement", "summary": "SOPHiA GENETICS SA (NASDAQ:SOPH) shares fell in after-hours trading after the company announced a proposed underwritten public offering of its ordinary shares. The healthcare technology company plans to sell ordinary shares, with an option for underwriters to purchase an addition", "url": "https://www.investing.com/news/stock-market-news/sophia-genetics-stock-falls-on-share-offering-announcement-93CH-4745748", "source_name": "Investing.com", "published_at": "2026-06-16T20:39:46", "published_display": "16 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA", "summary": "Philippe Menu, Chief Medical Officer of Sophia Genetics SA (SOPH), sold 5,000 shares on June 12, 2026, reducing his total holdings to 245,780 shares. This transaction is part of a trend for Sophia Genetics, which has seen 1 insider buy compared to 56 insider sells over the past y", "url": "https://www.gurufocus.com/news/8917174/insider-sell-philippe-menu-sells-5000-shares-of-sophia-genetics-sa", "source_name": "GuruFocus", "published_at": "2026-06-15T23:39:22", "published_display": "15 Jun 2026 23:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under Rule 10b5-1 plan", "summary": "SOPHiA GENETICS SA's Chief Medical Officer, Philippe Menu, sold 5,000 Ordinary Shares in an open-market transaction at a weighted average price of $4.9504 per share. This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was scheduled in ad", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-cf617045b0a8.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:10:32", "published_display": "15 Jun 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell Alert: Jurgi Camblong Sells 8,500 Shares of Sophia Genetics SA (SOPH)", "summary": "Jurgi Camblong, CEO of Sophia Genetics SA (SOPH), sold 8,500 shares of the company on June 10, 2026, bringing his total holdings to 3,620,995 shares. Sophia Genetics, specializing in AI-driven data analysis for healthcare, has seen significantly more insider selling than buying o", "url": "https://www.gurufocus.com/news/8913126/insider-sell-alert-jurgi-camblong-sells-8500-shares-of-sophia-genetics-sa-soph?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-12T10:10:18", "published_display": "12 Jun 2026 10:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock", "summary": "SOPHiA GENETICS CEO Jurgi Camblong sold 8,500 shares of SOPH stock on June 10th for $44,540, following several similar transactions in March and April. This sale reduces his direct ownership by 0.23% to 3,620,995 shares, valued at approximately $18.97 million. The company's stock", "url": "https://www.marketbeat.com/instant-alerts/jurgi-camblong-sells-8500-shares-of-sophia-genetics-nasdaqsoph-stock-2026-06-11/", "source_name": "MarketBeat", "published_at": "2026-06-11T21:36:51", "published_display": "11 Jun 2026 21:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CEO sells 8,500 shares under 10b5-1 plan", "summary": "SOPHiA GENETICS SA CEO Jurgi Camblong sold 8,500 Ordinary Shares at a weighted average price of $5.2354 per share. The sale was executed under a Rule 10b5-1(c) trading plan. Following this transaction, Camblong directly holds 3,620,995 shares.", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-e1f5f75b9f5a.html", "source_name": "Stock Titan", "published_at": "2026-06-11T19:39:51", "published_display": "11 Jun 2026 19:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting", "summary": "SOPHiA GENETICS has confirmed leadership changes ahead of its 2026 Annual General Meeting. Ross Muken will become CEO on July 1, 2026, and co-founder Dr. Jurgi Camblong is nominated for election as Chairman of the Board. This transition aims to provide strategic continuity and le", "url": "https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-confirms-leadership-transition-ahead-of-2026-912rcprt19ks.html", "source_name": "Stock Titan", "published_at": "2026-06-10T12:10:29", "published_display": "10 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI medicine player SOPHiA GENETICS hands CEO role to president Ross Muken", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPVXhBakRhWTRkTWFrYVR3LWRWQ3Y2Z0NIS1VWS2VBMGF5UmNhWXVGcWdWWDZLQzFVV0ozVGk4YnhpRmFPUGt6QW1mNVNHcWNIMmU0bjFDcmdWOUIxUzFtYmw0QUU5eTg1RTFyVHNTcFp5RUtyNllIQ2hiUERPd2IwWmJPWWdoUXl4QXRLSXpWUUZMVDhxUTcwZ25sSHViRjhvdGxCTkJCNXM1SFBZbUJkZEZtOVYwYWZW?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Spends US$99k Buying More Shares In SOPHiA GENETICS", "summary": "SOPHiA GENETICS' Executive VP & CFO, George Cardoza, recently purchased US$99k worth of shares at US$4.95 each, increasing his holdings by 6.9%. This insider transaction, the largest in the past year, indicates confidence in the company despite it having made a loss in the last y", "url": "https://finance.yahoo.com/markets/stocks/articles/insider-spends-us-99k-buying-134712873.html", "source_name": "Market source", "published_at": "2026-06-07T14:47:00", "published_display": "07 Jun 2026 14:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPH News | SOPHIA GENETICS SA (NASDAQ:SOPH)", "summary": "This article provides recent news and analysis for SOPHIA GENETICS SA (NASDAQ:SOPH), including financial results and strategic collaborations. Key updates mention mixed Q1 and Q4 2025 results with revenue beats, and significant partnerships for cancer testing. The stock is curren", "url": "https://www.chartmill.com/stock/quote/SOPH/news", "source_name": "ChartMill", "published_at": "2026-06-05T21:10:29", "published_display": "05 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] SOPHiA GENETICS SA Insider Trading Activity", "summary": "SOPHiA GENETICS SA's Chief Financial Officer, George Cardoza, purchased 20,000 Ordinary Shares at $4.95 each in an open-market transaction, increasing his direct holdings to 311,458 shares. This insider purchase, valued at $99,000, occurred during an open trading window and is hi", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-2ee56b9c4214.html", "source_name": "Stock Titan", "published_at": "2026-06-05T20:10:43", "published_display": "05 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG reiterates Sophia Genetics stock rating on strong Q1 growth", "summary": "BTIG has reiterated a Buy rating and an $8.00 price target on Sophia Genetics SA (NASDAQ:SOPH) after the company reported strong first-quarter revenue growth of 22%, surpassing analyst estimates. This growth was driven by increased volumes and the addition of 18 new customers, br", "url": "https://www.investing.com/news/analyst-ratings/btig-reiterates-sophia-genetics-stock-rating-on-strong-q1-growth-93CH-4662521", "source_name": "Investing.com", "published_at": "2026-06-05T01:09:36", "published_display": "05 Jun 2026 01:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ: SOPH) and MSK plan precision oncology hub MOU", "summary": "SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a Memorandum of Understanding (MOU) to explore a joint venture focused on establishing a precision oncology hub. This collaboration aims to combine MSK's extensive clinical data with SOPHiA GENETICS' Ai-", "url": "https://www.stocktitan.net/sec-filings/SOPH/6-k-sop-hi-a-genetics-sa-current-report-foreign-issuer-a362f2c8c20a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:44", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI cancer hub in the works as SOPHiA GENETICS teams with MSK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQenJzNlBySnVocGtnWEIteDByMUtpQW9DUDlxWDRjclVYeHhQU2ktRWNiVndTVG1Ca1VXRU1TVzJNaEVNaTYzVnd3MC12S29xZC16YVBsd2s2WHJrUHlsN2VNc3NUZV9FZUc0TGJyeEhiSktDMENhU2VpQmxSY0lkcGpDWTZxZmVqUjh2UFUwWS1YNVF3aExsLU9tNTE0WF9zZ2Q0cTY5UVdVQzNmMnFwcHIxa0d1MHlxRllN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,750.00 in Stock", "summary": "SOPHiA GENETICS (NASDAQ:SOPH) insider Philippe Menu sold 5,000 shares of the company's stock for $24,750 on May 26th, under a pre-arranged Rule 10b5-1 trading plan. This latest sale is part of frequent selling activity by Menu in recent months, though he still directly owns 250,7", "url": "https://www.marketbeat.com/instant-alerts/sophia-genetics-nasdaqsoph-insider-sells-2475000-in-stock-2026-06-01/", "source_name": "MarketBeat", "published_at": "2026-06-01T13:10:38", "published_display": "01 Jun 2026 13:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CMO of SOPHiA GENETICS (SOPH) sells 5,000 shares under Rule 10b5-1 plan", "summary": "Philippe Menu, Chief Medical Officer of SOPHiA GENETICS (SOPH), sold 5,000 Ordinary Shares on May 26, 2026, at a weighted average price of $4.9548 per share. This transaction was part of a pre-arranged Rule 10b5-1(c) trading plan. Following the sale, Menu still holds a substantia", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-a340d9f9d641.html", "source_name": "Stock Titan", "published_at": "2026-06-01T11:10:38", "published_display": "01 Jun 2026 11:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) president\u2019s 761-share tax sale under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSFZEWlZoRF9SVWl4MXBScW90ZUVDbkZqaGhIOXFpOWRJdHRvbDFJY0FaMDJ2ZzNmc01YYVZvVXJ2NUxzUy1HOHFJdGs2TVJWZ0dNampKdW5iTmVub0hhSFFqWFJXd1dFdllwbThCTVhHTmUtb3h4TDFwYkFlal81bm9obUlTc3hqdy03S2tCWlk1akprSUE2dklibE9PTjRNX1RteGI5QVRFZHFGc25HcHR1WDI?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Reports First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZy10Yk1HUXMzSlJyRGh4V0NoWThLOEVZTXB3M3dhenB5dWhOdUF3NnVTcmNHNkJTc1RzUHRxN2lIRDFUVVBJeTViSEJ6UHBZeTZYdWoweXRMcWJlRzRBUzJoejdyYXRlbFhUVnVfaXZSS3FDY3MtaHE1YTZHd09rY1l3aktOVHZxQXlReXB6LTlhbFNoeXZtbmtLSlV0UlF0UkczdklaYVRzQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPH Stock Price and Chart \u2014 NASDAQ:SOPH", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE8tWG95aGw4RTZXUUNCS1o3dm5qbkg1NXpDYVhad0tvWGtrWkFkU2ZIRzh5Z1RvNFktUXlLLU5GbFhQM1d0MV9EczhSdkFJSUk0TDl1a0xlUmJfcGdC?oc=5", "source_name": "TradingView", "published_at": "2022-07-22T07:00:00+00:00", "published_display": "22 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA: Shareholders Board Members Managers and Company Profile | CH1125843347", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNMmpuUHY0U0ZTSXBidHQ4bkRZeDJfS3NOTmxST1ROSE5sUHlGcTNYb083bDQ3cHZ2cW5zMklsc3F0VXQtQjQ3TnlDWXFudGM0Rk5UUnJiOFBnY2U0ck9nTjktZE5lQmdSY2hGbFN4M083Vk9KbHlxYTdmNEdWcGUtVWUyc1E3Zjg?oc=5", "source_name": "marketscreener.com", "published_at": "2021-08-14T09:11:51+00:00", "published_display": "14 Aug 2021 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA Stock (SOPH) - Quote Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9sNnk4MEpUbHR0TWZScUgzbFNvMUpYb2dBaldENmNfNzExb0Nqbmo0TDBvdWM2eFloVEtJZ09TTWN2MGlFLXhFcEFtYk1NREVJVTV6ak5PY0lRXzdSWmlndDZaQ3l2RV8xVXg2YWpnRUVFS25GeHU2SWlkdGg?oc=5", "source_name": "marketscreener.com", "published_at": "2021-07-25T09:18:59+00:00", "published_display": "25 Jul 2021 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOb1V3RUpSelQyV1M4TUpvN0h5TTZ6R1d1R3Z2ZkVBUWFtSGMxWFhFWkpobHpQYWJtTFR0eFlpU0l5UGVMRlRaWTUwM2ppWDlBdEVSM1hQbmd6LWhhclVFaFlQb0RUM2FrZTJScHlqRlFJMF9Bay1YakhqSjV2N3hYRS1ZbXFNb1F2cFFWSGlWT2dpcm9yYmtVdmJJQ1RTeTFpcllFcThmVXN5Nl9WZVZKT3Z1RXI4NXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T13:28:55+00:00", "published_display": "22 Jun 2026 13:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K", "summary": "SOPHiA GENETICS SA (SOPH) has filed a Form 6-K reporting the completion of an underwritten public offering of 12,104,900 ordinary shares at $4.75 per share, generating gross proceeds of approximately $57.5 million. The offering, which closed on June 18, 2026, included the full ex", "url": "https://www.stocktitan.net/sec-filings/SOPH/6-k-sop-hi-a-genetics-sa-current-report-foreign-issuer-c59327d1ba27.html", "source_name": "Stock Titan", "published_at": "2026-06-22T13:28:27", "published_display": "22 Jun 2026 13:28", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS raises USD 57.5 million through a public offering", "summary": "SOPHiA GENETICS, a leader in AI-driven precision medicine, successfully closed an oversubscribed public offering, raising $57.5 million. The company sold 12,104,900 ordinary shares at $4.75 each, with underwriters fully exercising their option for additional shares, signaling str", "url": "https://www.startupticker.ch/en/news/sophia-genetics-raises-usd-57-5-million-through-a-public-offering", "source_name": "Startupticker.ch", "published_at": "2026-06-22T07:11:27", "published_display": "22 Jun 2026 07:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares", "summary": "SOPHiA GENETICS has successfully closed a public offering of ordinary shares, raising $57.5 million. The offering included the full exercise of the underwriters' option to purchase additional shares, indicating strong market interest and investor confidence in the company. This c", "url": "https://www.fidelity.com/news/article/default/202606190800PR_NEWS_USPR_____NE87865", "source_name": "Fidelity", "published_at": "2026-06-20T01:39:03", "published_display": "20 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS closes $57.5M public offering By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPS19zMVg1VWk1ejVBeGRCOFF6VWUxaS1ndm4xWkJVSHVUSkotY1RSTExCUGJUZ2dJaXRTcFNOcDlUVkplVTNiOFN0Ny1rbDVNNVN1Y1QyMmJLbGQ0QjJTbmZHb1Q0YjlNWTgwZEE3blRhNWotamhDNlExNURueHcwZ2puOHQ2VGRPWE14NEJ2MnFzUGN6a09XQVFvdllmT05uaXFFTWNhOA?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-19T12:13:18+00:00", "published_display": "19 Jun 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS prices $50M public offering at $4.75 per share", "summary": "SOPHiA GENETICS has announced the pricing of a public offering of 10,526,316 ordinary shares at $4.75 per share, aiming to raise approximately $50 million before deductions. The offering is expected to close around June 21, 2024, and includes an option for underwriters to purchas", "url": "https://www.msn.com/en-us/money/topstocks/sophia-genetics-prices-50m-public-offering-at-475-per-share/ar-AA25PRq3", "source_name": "MSN", "published_at": "2026-06-19T00:40:21", "published_display": "19 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS: Strong Growth Meets A Critical Execution Phase (NASDAQ:SOPH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQd3V1dzdUbTJWeVFWQmRIZzlSaXdGMFI0Z1FiQXpTTDVFRHpsbEFZR1JGZDlMZjBscTNiUkFSVGhvMHEyNkNsamFvdGZ6REV0MW83b0dDUHVJakhvejdmWGx2YmpIUjlHaXVlcGMyNzZDZlJWZjYtc1R2amVwM0JkMDBVbzdvQ0V6QVBQekxzbU5lQXRVWjZ6R2R6XzgyQ2wwQUNnekN3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T12:22:59+00:00", "published_display": "18 Jun 2026 12:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics SA (SOPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZNGlrNlgzVWo0aDdEZjNkWG5Gd2lLUk04TzNLUWdZOXk2ZjJKdHJkYm5KMU9vaC0tTzVvUWJtRUI1N09feXpOYmRYc054eXd4ajlSTXZ0VWZTTHQ0WU5UdjVxWXRMVXhWR0N1UEpn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T08:30:21+00:00", "published_display": "18 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Zhenyu Xu Sells 4,000 Shares of Sophia Genetics SA", "summary": "Zhenyu Xu, the Chief Scientific Officer of Sophia Genetics SA, sold 4,000 shares of the company on June 15, 2026, reducing his total holdings to 622,280 shares. This transaction is part of a larger trend of insider selling at Sophia Genetics SA, with 57 insider sells against only", "url": "https://www.gurufocus.com/news/8921540/insider-sell-zhenyu-xu-sells-4000-shares-of-sophia-genetics-sa?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-18T01:09:16", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics SA (SOPH) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFB1UUR1VzhqaUx2anRxNDF1a0dvUGlUQ01oMHI2SlFEQWpVb2xtLUd1LWR1VUdPT1BiMDMtSUVnd0xpYkZNWjg5RUtYT1lCNkxfVVdkMUlGNU0wTVFPTnlObW1XUEFIbXRlNWhQVGl3U09FemhnZzVR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:07:49+00:00", "published_display": "17 Jun 2026 21:07", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) offers 10.53M shares; underwriters may add 1.58M", "summary": "SOPHiA GENETICS has announced an offering of 10.526 million ordinary shares at $4.75 per share, aiming to raise gross proceeds of approximately $49.998 million. Underwriters have an option to purchase an additional 1.578 million shares. The net proceeds, estimated at $45.9 millio", "url": "https://www.stocktitan.net/sec-filings/SOPH/424b5-sop-hi-a-genetics-sa-prospectus-supplement-debt-securities-e2a0f6414a7f.html", "source_name": "Stock Titan", "published_at": "2026-06-17T21:09:58", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CSO sells 4,000 shares under 10b5-1 plan", "summary": "SOPHiA GENETICS (SOPH) Chief Scientific Officer Xu Zhenyu sold 4,000 Ordinary Shares in an open-market transaction under a pre-arranged 10b5-1 trading plan. The shares were sold at a weighted average price of $5.0141, ranging from $4.90 to $5.13 per share. Following this transact", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-162eec7c9c8a.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:09:58", "published_display": "17 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPa2xWVnRvWUVZd0llN1dnWHlDc010cThiREItc05qOVpVNHRzZGNHTUJXdjJhRG8waExrbmdGSHZMdm9hVEI5U01UNUIxRjNKWWlCMDJGYUpkZ05LOVFXS0gyZHd2MElLRHBPalNlc2ZxbnRDaDkxMURid0VMVHlzZ0ZQMlZ0QTJaQWVpVHVnQlJMdDJHSG1aRVVIVUxhdC1ScWNvcmtnZjNkQVk0MkxLLWRJSG05cElzYm42enpqR25STWVyQ3JaZUw1U2RaODNFeUNwag?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-17T01:21:00+00:00", "published_display": "17 Jun 2026 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares", "summary": "SOPHiA GENETICS has announced a proposed public offering of its ordinary shares. This news was alerted to Quantisnow Plus members shortly after publication. Quantisnow, a market data and news platform, provides real-time alerts on various financial events including press releases", "url": "https://quantisnow.com/insight/sophia-genetics-announces-proposed-public-offering-of-ordinary-shares-6604860", "source_name": "Quantisnow", "published_at": "2026-06-17T00:09:58", "published_display": "17 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sophia Genetics (SOPH) Launches Public Offering of Ordinary Shar", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZC1FTHMtMlBwRHk3Sk5hZ2NxZmkxSFNXRUpDMW8tQ0JrcjFWZndyd0lWMVNZcmh4U2hTZVF5ZjM2Q0xBN2xZakw4SDZPY3gtRDdaaVBaY2RGc3B0Zk1XT3RUSXRhajFrLTlDZUcxcGhnUnRmSVJzV1djSWk3TDl4bWFwaVlmeHpSM2VsNDFCV0ZkTkZQRUV5MHBUZnZvenlFN2hTWW03bXJBUGRaZloxaGE5THYwUQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-16T21:55:21+00:00", "published_display": "16 Jun 2026 21:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ: SOPH) files supplement for share offering; $5.01 last trade", "summary": "SOPHiA GENETICS has filed a preliminary prospectus supplement for an ordinary share offering, which includes a 30-day option for underwriters to purchase additional shares. The company reported 71,790,366 ordinary shares outstanding as of March 31, 2026, with a last reported Nasd", "url": "https://www.stocktitan.net/sec-filings/SOPH/424b5-sop-hi-a-genetics-sa-prospectus-supplement-debt-securities-9462fbc95acb.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:39:46", "published_display": "16 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS plans new stock sale with option for 15% more shares", "summary": "SOPHiA GENETICS (Nasdaq: SOPH) announced a proposed underwritten public offering of its ordinary shares, with an option for underwriters to purchase an additional 15% of shares. All shares will be newly issued by the company, and the offering's size, price, and timing are subject", "url": "https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-proposed-public-offering-of-ordinary-q4oghzd1l1ic.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:39:46", "published_display": "16 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS stock falls on share offering announcement", "summary": "SOPHiA GENETICS SA (NASDAQ:SOPH) shares fell in after-hours trading after the company announced a proposed underwritten public offering of its ordinary shares. The healthcare technology company plans to sell ordinary shares, with an option for underwriters to purchase an addition", "url": "https://www.investing.com/news/stock-market-news/sophia-genetics-stock-falls-on-share-offering-announcement-93CH-4745748", "source_name": "Investing.com", "published_at": "2026-06-16T20:39:46", "published_display": "16 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA", "summary": "Philippe Menu, Chief Medical Officer of Sophia Genetics SA (SOPH), sold 5,000 shares on June 12, 2026, reducing his total holdings to 245,780 shares. This transaction is part of a trend for Sophia Genetics, which has seen 1 insider buy compared to 56 insider sells over the past y", "url": "https://www.gurufocus.com/news/8917174/insider-sell-philippe-menu-sells-5000-shares-of-sophia-genetics-sa", "source_name": "GuruFocus", "published_at": "2026-06-15T23:39:22", "published_display": "15 Jun 2026 23:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under Rule 10b5-1 plan", "summary": "SOPHiA GENETICS SA's Chief Medical Officer, Philippe Menu, sold 5,000 Ordinary Shares in an open-market transaction at a weighted average price of $4.9504 per share. This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was scheduled in ad", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-cf617045b0a8.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:10:32", "published_display": "15 Jun 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell Alert: Jurgi Camblong Sells 8,500 Shares of Sophia Genetics SA (SOPH)", "summary": "Jurgi Camblong, CEO of Sophia Genetics SA (SOPH), sold 8,500 shares of the company on June 10, 2026, bringing his total holdings to 3,620,995 shares. Sophia Genetics, specializing in AI-driven data analysis for healthcare, has seen significantly more insider selling than buying o", "url": "https://www.gurufocus.com/news/8913126/insider-sell-alert-jurgi-camblong-sells-8500-shares-of-sophia-genetics-sa-soph?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-12T10:10:18", "published_display": "12 Jun 2026 10:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock", "summary": "SOPHiA GENETICS CEO Jurgi Camblong sold 8,500 shares of SOPH stock on June 10th for $44,540, following several similar transactions in March and April. This sale reduces his direct ownership by 0.23% to 3,620,995 shares, valued at approximately $18.97 million. The company's stock", "url": "https://www.marketbeat.com/instant-alerts/jurgi-camblong-sells-8500-shares-of-sophia-genetics-nasdaqsoph-stock-2026-06-11/", "source_name": "MarketBeat", "published_at": "2026-06-11T21:36:51", "published_display": "11 Jun 2026 21:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) CEO sells 8,500 shares under 10b5-1 plan", "summary": "SOPHiA GENETICS SA CEO Jurgi Camblong sold 8,500 Ordinary Shares at a weighted average price of $5.2354 per share. The sale was executed under a Rule 10b5-1(c) trading plan. Following this transaction, Camblong directly holds 3,620,995 shares.", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-e1f5f75b9f5a.html", "source_name": "Stock Titan", "published_at": "2026-06-11T19:39:51", "published_display": "11 Jun 2026 19:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting", "summary": "SOPHiA GENETICS has confirmed leadership changes ahead of its 2026 Annual General Meeting. Ross Muken will become CEO on July 1, 2026, and co-founder Dr. Jurgi Camblong is nominated for election as Chairman of the Board. This transition aims to provide strategic continuity and le", "url": "https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-confirms-leadership-transition-ahead-of-2026-912rcprt19ks.html", "source_name": "Stock Titan", "published_at": "2026-06-10T12:10:29", "published_display": "10 Jun 2026 12:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI medicine player SOPHiA GENETICS hands CEO role to president Ross Muken", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPVXhBakRhWTRkTWFrYVR3LWRWQ3Y2Z0NIS1VWS2VBMGF5UmNhWXVGcWdWWDZLQzFVV0ozVGk4YnhpRmFPUGt6QW1mNVNHcWNIMmU0bjFDcmdWOUIxUzFtYmw0QUU5eTg1RTFyVHNTcFp5RUtyNllIQ2hiUERPd2IwWmJPWWdoUXl4QXRLSXpWUUZMVDhxUTcwZ25sSHViRjhvdGxCTkJCNXM1SFBZbUJkZEZtOVYwYWZW?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Spends US$99k Buying More Shares In SOPHiA GENETICS", "summary": "SOPHiA GENETICS' Executive VP & CFO, George Cardoza, recently purchased US$99k worth of shares at US$4.95 each, increasing his holdings by 6.9%. This insider transaction, the largest in the past year, indicates confidence in the company despite it having made a loss in the last y", "url": "https://finance.yahoo.com/markets/stocks/articles/insider-spends-us-99k-buying-134712873.html", "source_name": "Market source", "published_at": "2026-06-07T14:47:00", "published_display": "07 Jun 2026 14:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPH News | SOPHIA GENETICS SA (NASDAQ:SOPH)", "summary": "This article provides recent news and analysis for SOPHIA GENETICS SA (NASDAQ:SOPH), including financial results and strategic collaborations. Key updates mention mixed Q1 and Q4 2025 results with revenue beats, and significant partnerships for cancer testing. The stock is curren", "url": "https://www.chartmill.com/stock/quote/SOPH/news", "source_name": "ChartMill", "published_at": "2026-06-05T21:10:29", "published_display": "05 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] SOPHiA GENETICS SA Insider Trading Activity", "summary": "SOPHiA GENETICS SA's Chief Financial Officer, George Cardoza, purchased 20,000 Ordinary Shares at $4.95 each in an open-market transaction, increasing his direct holdings to 311,458 shares. This insider purchase, valued at $99,000, occurred during an open trading window and is hi", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-2ee56b9c4214.html", "source_name": "Stock Titan", "published_at": "2026-06-05T20:10:43", "published_display": "05 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG reiterates Sophia Genetics stock rating on strong Q1 growth", "summary": "BTIG has reiterated a Buy rating and an $8.00 price target on Sophia Genetics SA (NASDAQ:SOPH) after the company reported strong first-quarter revenue growth of 22%, surpassing analyst estimates. This growth was driven by increased volumes and the addition of 18 new customers, br", "url": "https://www.investing.com/news/analyst-ratings/btig-reiterates-sophia-genetics-stock-rating-on-strong-q1-growth-93CH-4662521", "source_name": "Investing.com", "published_at": "2026-06-05T01:09:36", "published_display": "05 Jun 2026 01:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ: SOPH) and MSK plan precision oncology hub MOU", "summary": "SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a Memorandum of Understanding (MOU) to explore a joint venture focused on establishing a precision oncology hub. This collaboration aims to combine MSK's extensive clinical data with SOPHiA GENETICS' Ai-", "url": "https://www.stocktitan.net/sec-filings/SOPH/6-k-sop-hi-a-genetics-sa-current-report-foreign-issuer-a362f2c8c20a.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:44", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI cancer hub in the works as SOPHiA GENETICS teams with MSK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQenJzNlBySnVocGtnWEIteDByMUtpQW9DUDlxWDRjclVYeHhQU2ktRWNiVndTVG1Ca1VXRU1TVzJNaEVNaTYzVnd3MC12S29xZC16YVBsd2s2WHJrUHlsN2VNc3NUZV9FZUc0TGJyeEhiSktDMENhU2VpQmxSY0lkcGpDWTZxZmVqUjh2UFUwWS1YNVF3aExsLU9tNTE0WF9zZ2Q0cTY5UVdVQzNmMnFwcHIxa0d1MHlxRllN?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,750.00 in Stock", "summary": "SOPHiA GENETICS (NASDAQ:SOPH) insider Philippe Menu sold 5,000 shares of the company's stock for $24,750 on May 26th, under a pre-arranged Rule 10b5-1 trading plan. This latest sale is part of frequent selling activity by Menu in recent months, though he still directly owns 250,7", "url": "https://www.marketbeat.com/instant-alerts/sophia-genetics-nasdaqsoph-insider-sells-2475000-in-stock-2026-06-01/", "source_name": "MarketBeat", "published_at": "2026-06-01T13:10:38", "published_display": "01 Jun 2026 13:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CMO of SOPHiA GENETICS (SOPH) sells 5,000 shares under Rule 10b5-1 plan", "summary": "Philippe Menu, Chief Medical Officer of SOPHiA GENETICS (SOPH), sold 5,000 Ordinary Shares on May 26, 2026, at a weighted average price of $4.9548 per share. This transaction was part of a pre-arranged Rule 10b5-1(c) trading plan. Following the sale, Menu still holds a substantia", "url": "https://www.stocktitan.net/sec-filings/SOPH/form-4-sop-hi-a-genetics-sa-insider-trading-activity-a340d9f9d641.html", "source_name": "Stock Titan", "published_at": "2026-06-01T11:10:38", "published_display": "01 Jun 2026 11:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS (SOPH) president\u2019s 761-share tax sale under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOSFZEWlZoRF9SVWl4MXBScW90ZUVDbkZqaGhIOXFpOWRJdHRvbDFJY0FaMDJ2ZzNmc01YYVZvVXJ2NUxzUy1HOHFJdGs2TVJWZ0dNampKdW5iTmVub0hhSFFqWFJXd1dFdllwbThCTVhHTmUtb3h4TDFwYkFlal81bm9obUlTc3hqdy03S2tCWlk1akprSUE2dklibE9PTjRNX1RteGI5QVRFZHFGc25HcHR1WDI?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS Reports First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZy10Yk1HUXMzSlJyRGh4V0NoWThLOEVZTXB3M3dhenB5dWhOdUF3NnVTcmNHNkJTc1RzUHRxN2lIRDFUVVBJeTViSEJ6UHBZeTZYdWoweXRMcWJlRzRBUzJoejdyYXRlbFhUVnVfaXZSS3FDY3MtaHE1YTZHd09rY1l3aktOVHZxQXlReXB6LTlhbFNoeXZtbmtLSlV0UlF0UkczdklaYVRzQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPH Stock Price and Chart \u2014 NASDAQ:SOPH", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE8tWG95aGw4RTZXUUNCS1o3dm5qbkg1NXpDYVhad0tvWGtrWkFkU2ZIRzh5Z1RvNFktUXlLLU5GbFhQM1d0MV9EczhSdkFJSUk0TDl1a0xlUmJfcGdC?oc=5", "source_name": "TradingView", "published_at": "2022-07-22T07:00:00+00:00", "published_display": "22 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA: Shareholders Board Members Managers and Company Profile | CH1125843347", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNMmpuUHY0U0ZTSXBidHQ4bkRZeDJfS3NOTmxST1ROSE5sUHlGcTNYb083bDQ3cHZ2cW5zMklsc3F0VXQtQjQ3TnlDWXFudGM0Rk5UUnJiOFBnY2U0ck9nTjktZE5lQmdSY2hGbFN4M083Vk9KbHlxYTdmNEdWcGUtVWUyc1E3Zjg?oc=5", "source_name": "marketscreener.com", "published_at": "2021-08-14T09:11:51+00:00", "published_display": "14 Aug 2021 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SOPHiA GENETICS SA Stock (SOPH) - Quote Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9sNnk4MEpUbHR0TWZScUgzbFNvMUpYb2dBaldENmNfNzExb0Nqbmo0TDBvdWM2eFloVEtJZ09TTWN2MGlFLXhFcEFtYk1NREVJVTV6ak5PY0lRXzdSWmlndDZaQ3l2RV8xVXg2YWpnRUVFS25GeHU2SWlkdGg?oc=5", "source_name": "marketscreener.com", "published_at": "2021-07-25T09:18:59+00:00", "published_display": "25 Jul 2021 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 38, "sentiment_summary": {"positive": 10, "negative": 11, "neutral": 17, "score": 52, "total": 38, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 19.05, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 11}, "market_context": {"has_market_context": true, "latest_close": 5.46, "latest_week": "2026-06-19", "one_week_move": 11.9, "four_week_move": 11.9, "twelve_week_move": 16.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.320908, "market_dynamics_buy_signal": false, "relative_strength": 2.557028, "fair_value_gap": 35.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.1537, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+11.9% over one week, +11.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 15}, {"label": "GuruFocus", "count": 4}, {"label": "TradingKey", "count": 2}, {"label": "PR Newswire", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "MarketBeat", "count": 2}, {"label": "marketscreener.com", "count": 2}, {"label": "Startupticker.ch", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 38}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "38", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+11.9% over one week, +11.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K"}], "updated_at": "2026-06-22T17:49:06.494815+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}